|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. Ca Cancer J Clin. 62:10–29. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wei F, Wu Y, Tang L, Xiong F, Guo C, Li X,
Zhou M, Xiang B, Li X, Li G, et al: Trend analysis of cancer
incidence and mortality in China. Sci China Life Sci. 60:1271–1275.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Quan Y, Song Q, Wang J, Zhao L, Lv J and
Gong S: MiR-1202 functions as a tumor suppressor in glioma cells by
targeting Rab1A. Tumor Biol. 39(101042831769756)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Allan BB, Moyer BD and Balch WE: Rab1
recruitment of p115 into a cis-SNARE complex: Programming budding
COPII vesicles for fusion. Science. 289:444–448. 2000.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Satoh A, Wang Y, Malsam J, Beard MB and
Warren G: Golgin-84 is a rab1 binding partner involved in golgi
structure. Traffic. 4:153–161. 2010.
|
|
7
|
Thomas JD, Zhang YJ, Wei YH, Cho JH,
Morris LE, Wang HY and Zheng XF: Rab1A is an mTORC1 activator and a
colorectal oncogene. Cancer Cell. 26:754–769. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu BH, Li XX, Wang HY and Zheng XS:
Overexpressed Rab1A is associated poor prognosis and promotes
oncogenic growth and metastasis through mTORC1 activation in
hepatocellular carcinoma. AACR, 2015.
|
|
9
|
Mukhopadhyay A, Nieves E, Che FY, Wang J,
Jin L, Murray JW, Gordon K, Angeletti RH and Wolkoff AW: Proteomic
analysis of endocytic vesicles: Rab1a regulates motility of early
endocytic vesicles. J Cell Sci. 124:765–775. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mukhopadhyay A, Quiroz JA and Wolkoff AW:
Rab1a regulates sorting of early endocytic vesicles. Am J Physiol
Gastrointest Liver Physiol. 306:G412–G424. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Charng WL, Yamamoto S, Jaiswal M, Bayat V,
Xiong B, Zhang K, Sandoval H, David G, Gibbs S, Lu HC, et al:
Drosophila tempura, a novel protein prenyltransferase α subunit,
regulates notch signaling Via Rab1 and Rab11. PLoS Biol.
12(e1001777)2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang C, Yoo Y, Fan H, Kim E, Guan KL and
Guan JL: Regulation of Integrin β 1 recycling to lipid rafts by
Rab1a to promote cell migration. J Biol Chem. 285:29398–29405.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tanaka M, Mun S, Harada A, Ohkawa Y,
Inagaki A, Sano S, Takahashi K, Izumi Y, Osada-Oka M, Wanibuchi H,
et al: Hsc70 contributes to cancer cell survival by preventing
Rab1A degradation under stress conditions. PLoS One.
9(e96785)2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Salem A, Almahmoudi R, Listyarifah D,
Siponen M, Maaninka K, Al-Samadi A, Salo T and Eklund KK: Histamine
H4 receptor signalling in tongue cancer and its
potential role in oral carcinogenesis-a short report. Cell Oncol
(Dordr). 40:621–630. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Coune PG, Bensadoun JC, Aebischer P and
Schneider BL: Rab1A over-expression prevents Golgi apparatus
fragmentation and partially corrects motor deficits in an
alpha-synuclein based rat model of Parkinson's disease. J
Parkinsons Dis. 1:373–387. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wu G, Yussman MG, Barrett TJ, Hahn HS,
Osinska H, Hilliard GM, Wang X, Toyokawa T, Yatani A, Lynch RA, et
al: Increased myocardial Rab GTPase expression: A consequence and
cause of cardiomyopathy. Circ Res. 89:1130–1137. 2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba
M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of
RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921.
2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu H, Qian M, Zhao B, Wu C, Maskey N, Song
H, Li D, Song J, Hua K and Fang L: Inhibition of RAB1A suppresses
epithelial-mesenchymal transition and proliferation of
triple-negative breast cancer cells. Oncol Rep. 37:1619–1626.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang X, Liu F, Qin X, Huang T, Huang B,
Zhang Y and Jiang B: Expression of Rab1A is upregulated in human
lung cancer and associated with tumor size and T stage. Aging
(Albany NY). 8:2790–2798. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu BH, Li XX, Yang Y, Zhang MY, Rao HL,
Wang HY and Zheng XF: Aberrant amino acid signaling promotes growth
and metastasis of hepatocellular carcinomas through Rab1A-dependent
activation of mTORC1 by Rab1A. Oncotarget. 6:20813–20828.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Thomas JD, Zhang YJ, Wei YH, Cho JH,
Morris LE, Wang HY and Zheng XFS: Rab1A Is an mTORC1 activator and
a colorectal oncogene. Cancer Cell. 26:181–182. 2016.
|
|
22
|
Fan SJ, Snell C, Turley H, Li JL,
McCormick R, Perera SM, Heublein S, Kazi S, Azad A, Wilson C, et
al: PAT4 levels control amino-acid sensitivity of
rapamycin-resistant mTORC1 from the Golgi and affect clinical
outcome in colorectal cancer. Oncogene. 35:3004–3015.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
et al: Bladder cancer: Epidemiology, staging and grading, and
diagnosis. Urology. 66 (6 Suppl 1):S4–S34. 2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Herr HW: Pathologic evaluation of radical
cystectomy specimens. Cancer. 95:668–669. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hutagalung AH and Novick PJ: Role of Rab
GTPases in membrane traffic and cell physiology. Physiol Rev.
91:119–149. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li Y, Wang HY and Zheng XF: Rab1 GTPases
as oncogenes. Aging (Albany NY). 7:897–898. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
RAB1A Promotes Oncogenesis in Colorectal
Cancer via mTORC1 Activation. Cancer Discovery. 4:1366. 2014.
|
|
28
|
Yang XZ, Wang R, Li XX, Yang Y, Wang HY
and Zheng XS: Rab1A and Rab1B promote esophageal squamous cell
carcinoma through activating mTORC1 signaling and inhibiting
autophagy. AACR, 2016.
|
|
29
|
Zavadil J, Haley J, Kalluri R, Muthuswamy
SK and Thompson E: Epithelial-mesenchymal transition. Cancer Res.
68:9574–9577. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Seton-Rogers S: Epithelial-mesenchymal
transition: Untangling EMT's functions. Nat Rev Cancer.
16(1)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Becker MN, Wu KJ, Marlow LA, Kreinest PA,
Vonroemeling CA, Copland JA and Williams CR: The combination of an
mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder
cancer in vitro. Urol Oncol. 32:317–326. 2014.PubMed/NCBI View Article : Google Scholar
|
